FRONTLINE® becomes ‘Brand of the Year’ 2019-2020 in World Branding Awards

Ingelheim, Germany, Thu, 07/04/2019 - 08:30

FRONTLINE^® was named global ‘Brand of the Year’ (Animalis Edition) for 2019-2020
The Award scores are predominantly constituted by consumer votes
World Branding Awards recognise and celebrate some of the best global, regional and national brands for their work and achievement

Ingelheim, Germany, 4 July 2019 – Boehringer Ingelheim, a global leader in animal health, is proud to announce that its FRONTLINE® brand was named global ‘Brand of the Year’ 2019-2020 in the Animalis Edition of the World Branding Awards.

The organiser of the World Branding Awards, World Branding Forum, headquartered in London, UK, is a non-profit organisation, dedicated to advancing branding standards for the good of the branding community as well as consumers. It organises and sponsors a range of educational programmes, including collaborations with leading universities and museums.

The winners are judged through three streams: brand valuation, consumer market research and public online voting. Over 95,000 pet and animal lovers from around the world voted for their favourite brand, in 38 countries, across six continents for the 2019-2020 Animalis Edition of the Awards.

“This is a celebration of the continuous effort that is vital to build outstanding brands. As consumer votes constitute 70 per cent of the final score, winners of the Awards must have strong brand recall among their consumers,” explained Richard Rowles, Chairman, World Branding Forum.

Damien Martin, Global Head of Pet Healthcare, shared: “We are absolutely delighted to have won this global Award. The Award recognises our teams who work tirelessly ensuring brand awareness is high and people know what our brands stand for in the ever-changing pet and animal health industry.”

Boehringer Ingelheim Animal Health Business Unit

Boehringer Ingelheim is the second largest animal health business in the world, with net sales of almost 4 billion euros in 2018 and presence in more than 150 markets.

Across the globe, our 10,000 employees create the future of animal wellbeing through their daily work. We believe in prevention over treatment and therefore, we focus on developing innovative solutions in the field of vaccines, parasiticides and therapeutics. With a large portfolio of advanced, preventive healthcare products, tools and services, we support our customers in taking care of the health of their animals.

For more information visit: www.boehringer-ingelheim.com/animal-health/overview.

World Branding Forum

World Branding Forum (WBF) is a global, non-profit organisation dedicated to advancing branding standards for the good of the branding community as well as consumers. This includes those who work in the branding, design, marketing, advertising, public relations and communications disciplines worldwide. The WBF produces, manages and supports a wide range of programmes covering research, development, education, recognition, networking and outreach. For more information, visit www.brandingforum.org.

Boehringer Ingelheim

Improving the health of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.

Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2018, Boehringer Ingelheim achieved net sales of around 17.5 billion euros. R&D expenditure of almost 3.2 billion euros, corresponded to 18.1 per cent of net sales.

As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.

More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.

Intended audiences:

This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.